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Tolerogenicity of dendritic cells (DCs) has initially been attributed exclusively to imma-
ture/resting stages, while mature/activated DCs were considered strictly immunogenic.
Later, all different subsets among the myeloid/conventional DCs and plasmacytoid DCs
have been shown to bear tolerogenic potential, so that tolerogenicity could not be attrib-
uted to a speciﬁc subset. Immunosuppressive treatments of immature DC subsets could
prevent re-programming into mature DCs or upregulated inhibitory surface markers or
cytokines. Furthermore, the differentT cell tolerancemechanisms anergy, deletion, immune
deviation, and suppression require different quantities and qualities of costimulation by
DCs. Since expansion of regulatoryT cells (Tregs) has been shown to be promoted best by
fully mature DCs the role of CD80/B7-1 and CD86/B7-2 as major costimulatory molecules
forTreg biology is under debate. In this review, we discuss the role of these and other cos-
timulatory molecules on myeloid DCs and their ligands CD28 and CD152/CTLA-4 onTregs
for peripheral conversion from naive CD4+ T cells into the major subsets of Foxp3+ Tregs
and Foxp3− IL-10+ regulatory type-1T cells (Tr1) orTr1-like cells and their role for peripheral
maintenance in the steady state and after activation.
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SUBSETS OF Tregs
Regulatory T cells can be generated in the thymus and are released
as so-called natural regulatory T cells (nTregs) or by extrathymic
induction from naive T cells (iTregs) in secondary lymphoid
organs (Horwitz et al., 2008; Sakaguchi et al., 2008; Yamazaki and
Steinman, 2009). Several Treg subsets or functional states, depend-
ing on their anatomical origin or mode of generation, have been
described (Sakaguchi et al., 2008) but a common signature or dis-
tinct sublineages may not exist (Feuerer et al., 2010). Two major
subtypes of iTregs can be distinguished on the basis of their Foxp3
expression. Many authors refer only to the Foxp3+ subtypes as
iTregs, while the Foxp3− IL-10+ T cells are mostly named Tr1
(T regulatory type-1) or Tr1-like cells (Figure 1). Of note, most
activated Tregs seem to release IL-10, independent of their Foxp3
expression (Figure 1). Since these Treg subsets have been in focus
the last years, there is ample information about their interaction
with DCs and this will be discussed here. In contrast, the less well
investigated IL-35+ Tregs and TGF-β-producing Th3 or CD8+
Tregs are reviewed elsewhere (Filaci and Suciu-Foca, 2002; Wang,
2008; Bettini andVignali, 2009;Weiner et al., 2011). Since the gen-
eration of nTregs in the thymus seems not to depend on DCs but
B7 costimulation on medullary epithelial cells and other APCs, we
also refer to other reviews (Kyewski and Klein, 2006; Ohkura and
Sakaguchi, 2010).
The best studied costimulatory molecules are CD80 (B7-1) and
CD86 (B7-2). Both B7 molecules are the ligands of CD28 and
Abbreviations: APC, Antigen-presenting cells; DC, dendritic cell; iTreg, induced
regulatory T cells; nTreg, natural regulatory T cells; Tr1, T regulatory type-1; Th1, T
helper 1; Th2, T helper 2; Th17, T helper 17.
CTLA-4 receptors on T cells (Lenschow et al., 1993). Whereas
signaling by B7/CD28 pathway is crucial for enhancing T cell
activation and survival, signaling by B7/CTLA-4 mainly regulates
inhibitory T cell responses (Sansom and Walker, 2006). Moreover,
selectivity for CD28 to CD86 and CTLA-4 to CD80 interactions
may have to be considered due to stoichiometric and afﬁnity
measurements in vitro (Collins et al., 2002).
ROLE OF COSTIMULATION FOR THE GENERATION OF Tr1
CELLS
MOLECULAR FACTORS DRIVING IL-10 IN T CELLS
Initial reports deﬁned Tr1 cells as IL-10 producing T cells which
developed from naive T cells and acquired suppressive activity in
the presence of IL-10. They adapted a particular cytokine expres-
sion proﬁle distinct from Th1 or Th2 effector T cells (Groux et al.,
1997). However, ever since,many IL-10 producing Tregs have been
described that could be induced under various experimental con-
ditions (Table 1) and as reviewed in Hawrylowicz and O’Garra
(2005), Roncarolo et al. (2006). Interestingly, high production of
IL-10 and acquisition of regulatory function can also occur as a
result of chronic stimulationof differentiatedThelper cells thereby
gradually losing production of effector cytokines such as IFN-
γ or IL-4 (O’Garra et al., 2004). The question remains whether
all Foxp3− IL-10+ iTregs cells that are either derived from naive T
cell precursors (Tr1) or from chronically stimulated effector T cells
(Tr1-like) develop via similar IL-10- and costimulation-dependent
signaling mechanisms. To date this remains unclear. However, for
Th1-like cells common signaling pathways have been reported.
Saraiva et al. identiﬁed the mitogen-activated protein kinases
Erk1 and Erk2 along with strong T cell receptor (TCR) triggering
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FIGURE 1 | Generation and maintenance of differentTreg subsets and
their costimulation requirements. During the steady state thymus
derived Foxp3+ nTregs require IL-2 and B7 (CD80/CD86) costimulation to
persist. The conversion of iTregs from naiveT cells into the Foxp3+ subtype
prefers the absence of B7 molecules but requires the presence of TGF-β
and IL-2. Strong B7 costimulation favors the activation of both Foxp3+
nTregs and Foxp3+ iTregs such as provided by mature DCs. Generation of
Tr1 cells from naiveT cells requires the presence of costimulation and IL-10.
The appearance of Tr1-like cells is preceded by immunogenic Th1 (by IL-12),
Th2 (by IL-4), or Th17 (by TGF-β/IL-6) induction and subsequent short interval
restimulations under the same immunogenic conditions that will result in a
loss of theTh phenotype and a gain of IL-10 production capacity. Of note, all
events indicated by arrows require TCR signals in addition.
and activation of the respective signal transducer and activator
of transcription (STAT) as a common signaling pathway for the
production of IL-10 by Th1, Th2, or Th17 effector T cells (Saraiva
et al., 2009; Saraiva and O’Garra, 2010). Motomura et al. (2011)
further supported the concept of a common signaling cascade for
the appearance of IL-10 by effector T cells by identifying the cen-
tral transcription factor E4 promoter-binding protein 4 (E4BP4),
also known as NFIL3, essential for the regulation of both the IL-13
and IL-10 expression in chronically stimulated Th1 cells and other
innate cells. Further research is needed to clarify the signaling
pathways in T cells upstream of E4BP4 and the role DC-derived
costimulatory molecules in this process.
IL-10 AND THE DEVELOPMENT OF Tr1 CELLS
Whereas the role of DC maturation and costimulation for the
generation of Tr1 cells has remained poorly investigated, the
requirement of IL-10 is well documented (Groux et al., 1997; Lev-
ings et al., 2005; Roncarolo et al., 2006). Indeed, differentiation of
Tr1 by means of immunosuppressive drugs such as dexametha-
sone and vitamin D3 is inhibited even in APC-free conditions
in the presence of anti-IL-10R antibodies (Barrat et al., 2002).
Other studies on Tr1 differentiation by human immature DCs
suggested that DC-derived IL-10 is critical for the generation of
Tr1 cells (Levings et al., 2005; Gregori et al., 2010; van der Aar
et al., 2011). The use of IL-10 reporter mice indicated that mouse
Tr1 cells can develop in vivo in the absence of IL-10 (Maynard
et al., 2007). It has been discussed whether IL-10 may only be
required to maintain T cell anergy of Tr1 cells (Roncarolo et al.,
2006). In this scenario IL-10modulates theDCorAPCmaturation
phenotype rather than through direct activity on T cells (Wakkach
et al., 2001). Indeed, IL-10 is a potent down-modulator of MHC
II and costimulatory molecule expression on DCs (Moore et al.,
2001; Sato et al., 2002; Gabrysova et al., 2009; Gregori et al., 2010).
Immature DCs cultured in the presence of additives such as IL-10,
TGF-β, glucocorticoids or vitaminD3 analogs or lowdoses of GM-
CSF can acquire even a maturation-resistant DC phenotype, thus
remaining strictly immature and generating anergic T cells in vitro
(Lutz, 2006). However, not all such anergic T cells gain regulatory
capacity (Berger et al., 2009). It remains open whether this can be
explained by the fact that T cell anergy can result either in complete
absence of CD80/CD86 signals or by CD80/CD86 engagement of
CTLA-4 (Greenwald et al., 2001; Macian et al., 2004).
COSTIMULATION THROUGH CD80, CD86, CD58, AND ICOS-L
The initial report used murine splenic APCs or human mono-
cytes to differentiate Tr1 cells (Groux et al., 1997). Low levels
of CD80/CD86 molecules are provided by both cellular sources.
However, the requirement for CD28 or CTLA-4 signals for Tr1
cell generation have initially not been addressed. Several reports
demonstrated that Tr1 cells typically express large amounts of
CTLA-4 regardless of the effector T cell type the cells were origi-
nally derived from (Table 1). Indeed, Perez et al. (2008) demon-
strated that preferential ligation of CTLA-4 by CD80 on mature
DCs resulted in anergic T cells bearing suppressive activity and
producing high amounts of IL-10 upon restimulation. Although
the presence of anti-IL-10R antibodies abolished the differen-
tiation of iTregs in this culture set-up, IL-10 production itself
appeared largely dependent on CTLA-4 signaling (Perez et al.,
2008). A role of CD58–CD2 interaction for human Tr1 has been
proposed on the basis of studies using CD58-transfected artiﬁcial
APCs (Levings et al., 2001; Wakkach et al., 2001). Since CD58 is
not a ligand for CD2 in the mouse, this pathway may not follow a
general rule for Tr1 generation.
Others claimed that only immature DCs contributed to the
differentiation of IL-10 producing Tr1 cells (Jonuleit et al., 2000;
Levings et al., 2005). However, those human immature monocyte-
derived DCs (although largely CD83 negative) express substantial
CD80 and CD86 on their cell surface (Jonuleit et al., 2000; Gre-
gori et al., 2010) and appear thereby rather semi-mature (Lutz
and Schuler, 2002), whereas these markers can be hardly detected
on freshly isolated Langerhans cells (McIlroy et al., 2001), splenic
DCs (Berthier-Vergnes et al., 2001), or liver perfusate DCs (Bosma
et al., 2006) from human donors. Only human DCs isolated from
thymus or tonsils showed substantial expression of costimula-
tory markers (Summers et al., 2001; Vandenabeele et al., 2001).
In addition, human Tr1 cells could be differentiated in the pres-
ence of exogenous IL-10 and monocyte-derived DCs, which did
not produce IL-12p70 but expressed high levels of costimulatory
molecules on their surface (Gregori et al., 2010). Thus, costimu-
lation through CD80/CD86 as provided by semi-mature DCs, but
not by truly immature DCs, is required to generate IL-10+ T cells
from naive precursors (Figure 1).
Secretion of IL-10 for both Foxp3+ Treg or Tr1 cells has been
linked to high ICOS surface expression (Hutloff et al., 1999;Akbari
et al., 2002; Herman et al., 2004). Costimulation via ICOS-L
(CD275) on the surface of mature myeloid DCs (Witsch et al.,
2002) or mature plasmacytoid DCs (Ito et al., 2007) stimulates
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IL-10 release byTr1orTr1-like cells, respectively. Enhanced expres-
sion of ICOSon in vitro generatedTr1 cells has also been attributed
to the cytokine IL-27 (Pot et al., 2009). IL-27 can be produced by
DCs upon interaction with Foxp3+ Tregs, which acquire a par-
ticular plasmacytoid-like DC phenotype expressing costimulatory
molecules able to generate Tr1 cells (Awasthi et al., 2007). Human
immature DCs speciﬁcally upregulate PD-L1 in the presence of
exogenous IL-27 (Karakhanova et al., 2011). Further research is
needed to deﬁne the role of a DC maturation phenotype in dif-
ferentiation of Tr1 cells driven by exogenous IL-27 as most studies
are performed under APC-free culture conditions.
Thus, some extent of costimulation by DCs seems necessary
for the generation of Tr1 cells despite the fact that a variety of
approaches have used“immature”DCs to generate Tr1 cells in vitro
(Table 1).
COSTIMULATION FOR Tr1-LIKE CELLS BY CHRONIC
STIMULATION OF EFFECTOR T CELLS OR DURING INFECTION
PLASTICITY OF T CELLS FOR PRODUCTION OF CYTOKINES OTHER THAN
IL-10
The concept of classical lineage commitment into Th1, Th2, and
others has been challenged by recent work and it is suggested now
that T cells show substantial functional plasticity in their cytokine
secretion (O’Shea and Paul, 2010). As an example, IL-13 and IL-
10 production by Th1 cells could be demonstrated upon chronic
stimulation through TCR and CD28 pathways (Motomura et al.,
2011). The Tr1 cells described by Roncarolo and colleagues require
IL-10 for their generation and thenproduce IL-10, some IFN-γ and
IL-5 but no IL-4 (Groux et al., 1997; Levings et al., 2001). Origi-
nally IL-10 (but also IL-5 and IL-13) was deﬁned as a classical Th2
cytokine, however, the mechanisms and/or costimulatory signals
initiating IL-10 production in Th2 cells remained unclear (Moore
et al., 2001). Expression of IL-10 by Th2 memory cells has been
attributed to repetitive TCR receptor signaling and continuous IL-
4 signals (Lohning et al., 2003; Chang et al., 2007). Alternatively, it
is well established that the differentiation of IL-10 and IL-4 pro-
ducing Th2 cells is CD28-signaling dependent but inhibited by
CTLA-4 (Bour-Jordan et al., 2003; Coquerelle et al., 2009; Hunig
et al., 2010). Indeed, injection of anti-CTLA-4 antibodies in the
presence of splenic DCs induced ICOS+ Tregs producing both
IL-4 and IL-10 (Coquerelle et al., 2009). In contrast, triggering
CTLA-4 signaling on Th1 cells by CD80 from mature DCs seems
to promote IL-10 secretion and Tr1 differentiation (Perez et al.,
2008). These observations not only emphasize the necessity of DC
costimulation for the induction of IL-10 secretion in effector T
cells but in addition suggest that CTLA-4 and CD28 might have
opposing functions dependent on the initial differentiation pro-
gram that shaped the original Th1 or Th2 cells. Furthermore, since
DC-derived signals are essential in directing differential T helper
cell phenotypes, it is tempting to speculate that the common sig-
nature regulating IL-10 expression in T cells is in fact driven by
DC-derived costimulatory signals.
Tr1-LIKE CELLS GENERATED BY TNF OR β-CATENIN STIMULATED
SEMI-MATURE DCs
Many groups, including ours, searched intensively for the DC mat-
uration phenotype that differentiates IL-10+ Tr1-like cells from
either Th1 or Th2 cells and whether this would result in tolerance
or immunity (Lutz and Schuler, 2002; Lutz, 2006; Tarbell et al.,
2006). Tr1-like cell generation might be initiated by triggering the
β-catenin pathway in DCs, at least when induced by disrupting E-
cadherin mediated homotypic interactions between DCs or after
inﬂammatory stimulation of the DCs (Menges et al., 2002; Spörri
andReis e Sousa, 2005; Jiang et al., 2007). TheseDCs show a partic-
ular semi-mature phenotype characterized by high expression of
MHC II and B7 costimulatory molecules but absence of cytokine
secretion (Menges et al., 2002; Spörri and Reis e Sousa, 2005).
Repetitive injections of such semi-mature DCs prevented the
induction of experimental autoimmune encephalomyelitis (EAE)
by inducing IL-10+ Tr1-like cells (Menges et al., 2002; Jiang et al.,
2007) but also IL-4+ and IL-13+ T and NKT cells (Wiethe et al.,
2007). Such TNF-stimulated semi-mature DCs were also protec-
tive in models of thyroiditis (Verginis et al., 2005) but failed to
prevent CD8-mediated type-1 diabetes (Kleindienst et al., 2005).
Surprisingly, semi-mature DCs deﬁcient for the coinhibitory lig-
and PD-L1 (CD274) showed an increased induction of IL-10 and
IL-13 secreting CD4+ T cells in vivo, indicating that PD-1 signals
counteract Tr1-like cell induction (Brandl et al., 2010).
It remains open at this point whether DC matura-
tion/costimulation proﬁles inducing either Th2 effector cell dif-
ferentiation or tolerogenic Tr1-like cells are different or identical.
Tr1-LIKE CELLS DERIVED FROM Th2 CELLS
Although repetitive injections of antigen-loaded semi-mature DC
were able to prevent Th1-mediated diseases by inducing increasing
numbers of Th2-derived Tr1-like cells with each injection (Menges
et al., 2002), the same regimen failed to suppress Th2-mediated
footpad swelling in a Leishmania major infection model (Wiethe
et al., 2008). However, Th1-derived Tr1-like cells effectively sup-
pressed immunity in a Th1-polarized, chronic, non-healing Leish-
mania major infection model (Anderson et al., 2007).Whether the
differences in protection depend on the model or on differences
between Th1- or Th2-derived Tr1-like cells remains unresolved.
In murine parasitic infection models such as Trypanosoma brucei,
Schistosoma mansoni, and Echinococcus multilocularis a cytokine
shift to anti-inﬂammatory IL-10, IL-4, and IL-13has been reported
which is believed to protect the host from extensive tissue damage
(Perona-Wright et al., 2006; Stijlemans et al., 2007; MacDonald
and Maizels, 2008; Vuitton and Gottstein, 2010). The Th2/Tr1-
like proﬁle induced by helminth-derived secretory products of S.
mansoni eggs or Nippostrongylus brasiliensis excretory/secretory
antigens have been shown to result in partial DCmaturation (Balic
et al., 2004; Perona-Wright et al., 2006). Together, parasites or their
products result in immature or semi-mature DC signatures,which
trigger mild TCR and costimulatory signaling cascades and result
in Th2/Tr1-like polarizations. However, how DC maturation sig-
natures regulate the master switch leading to IL-10 production in
Th2 or Tr1-like cells remains to be shown.
Tr1-LIKE CELLS DERIVED FROM Th1 CELLS
The ability of Th1 differentiated T cells to produce IL-10 upon
chronic stimulation is very well documented (Table 1). DCs direct
Th1 differentiation as fully mature DCs by providing high TCR
and costimulatory signaling in the presence of IL-12p70 cytokine
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secretion (Kapsenberg, 2003) or via CD70 signals (Soares et al.,
2007). As a difference between Th1- or Th2-derived Tr1-like cells,
chronic Th1 stimulation seems to be required for Tr1-like cell
generation, while IL-10 release by Th2 effector T cells may occur
immediately (Lohning et al., 2003; Motomura et al., 2011). Sev-
eral reports indicated that the presence of IL-12 released by DCs
is essential for IL-10 production in Th1 cells mediated by sus-
tained STAT-4 signaling (Chang et al., 2007; Rutz et al., 2008;
Saraiva et al., 2009). Also a high antigen dose favors their IL-10
production (Saraiva et al., 2009). IL-10 induction in Th1 cells
was abrogated when DC were deﬁcient in IL-12p40 production
suggesting that IFN-γ produced by Th1 cells induced continuous
IL-12 production in DCs by a feedback loop (Saraiva et al., 2009).
Alternatively, complement factors, which could be produced
locally as a result of cognate DC-T cell interactions, regulated the
expression of MHC II, costimulatorymolecules and IL-12p70 pro-
duction (Heeger and Kemper, 2011). Repetitive engagement of
the complement regulator proteins CD46 or CD55 on human T
cells induced IL-10 production from Th1 cells although addition
of exogenous IL-2 was required (Capasso et al., 2006; Cardone
et al., 2010), similar as for the generation of human Tr1 cells
in vitro (Groux et al., 1997; Jonuleit et al., 2000; Levings et al.,
2005). It remains open how the CD55 receptor CD97 is regu-
lated on the DC surface. Of note, Th1 cells, which acquire the
ability to produce IL-10, gradually lose their expression of IL-2
(Gabrysova et al., 2009; Saraiva et al., 2009). Sustained IL-12 dri-
ven STAT-4 signaling is also required for the IL-10 production in
IFN-γ-secreting Th1 cells induced by Notch signaling (Rutz et al.,
2008). Hence, it is tempting to speculate that chronic stimulations
by DCs shift the intrinsic T cell polarization proﬁle from IFN-γ
to IL-10 production. Radbruch and colleagues showed that Th1
cells up-regulate the transcription factorTwist1,which requires IL-
12 induced STAT-4 signaling for suppression of the Th1-effector
cytokines IFN-γ, IL-2, andTNF (Niesner et al., 2008). It is worth to
speculate whether this shift might be supported through CTLA-4
signals since gradual CTLA-4 upregulation by Tr1-like cells differ-
entiated from Th1 cells has been observed regularly (Table 1). In a
rejection model for organ transplantation, Th1 cells adapt to per-
sistent antigen stimulation by upregulation of inhibitory surface
molecules and cytokines such asCTLA-4,Twist1, and IL-10 (Noval
Rivas et al.,2009). Earlier studies demonstrated thatT cells exposed
to chronic antigen stimulation down-modulate effector cytokine
secretion during the process of so-called adaptive tolerance (Singh
and Schwartz, 2003).
Together, IL-12 production by DCs seems to be critical for the
induction of IL-10 in Th1 cells by triggering sustained STAT-4 sig-
naling. Whether the low expression of CD80/CD86 on immature
DCs is sufﬁcient or rather semi-mature or mature DCs stages are
required remains open.
COSTIMULATION FOR DIFFERENT Foxp3− IL-10+ iTreg TYPES
IN VIVO
LUNG
The generation of Tr1-like cells has been reported also in the
absence of overt infections (Table 1). However, Tr1-like cell induc-
tion may require some commensal stimulation during steady state
conditions through TLRs for both Th1 and Th2 responses. The
mucosal application route may favor a Th2 outcome as sup-
ported by experiments where exogenous antigens were adminis-
tered intranasally. The antigens could enter the respiratory but
also gastrointestinal tracts and migratory DC transported the
intranasally applied antigens to the draining lymph nodes to
induce Th2 responses (Constant et al., 2000; Piggott et al., 2005;
Derbyshire et al., 2011). Studies by Umetsu and colleagues showed
that high dose antigen exposure through intranasal routes caused
pulmonary DCs to mature and migrate into the draining lymph
nodes where they induced IL-10 and IL-4 secreting Tr1-like cells
protecting mice from airway hyper-reactivity (Akbari et al., 2001,
2002). Moreover, Akdis et al. (2004) demonstrated that a ﬁne-
tuned balance between aeroallergen-speciﬁc Tr1-like and Th2 cells
exists in allergic or healthy patients, which may regulate allergy to
common environmental proteins. How DCs or lung epithelium
contribute to the generation of Th2 effector cells in lung-draining
lymph nodes has been studied intensively (Hammad and Lam-
brecht, 2008). A mature DC signature has been revealed only by
one study (Akbari et al., 2001), possibly resulting from minute
amounts of endotoxin to allow DC maturation and indicating
that costimulation would be required to induce Tr1-like cells.
INTESTINE
In contrast, the oral tolerance phenomenon seem to be depen-
dent largely on DCs present in the lamina propria and mesenteric
lymph nodes as shown upon administration of sugar-modiﬁed
antigens, which trigger differentiation of IL-10 and IFN-γ pro-
ducing Tr1-like cells (Worbs et al., 2006; Zhou et al., 2010). It has
been suggested that the presence of gut microbiota and hence,
the particular IL-10+ semi-mature DC signature present under
these conditions, contributes to the IL-10 production also of the
T cells (Hrncir et al., 2008; Monteleone et al., 2008). TLR-2 has
been previously reported to promote IL-10 production by DCs
and respective Treg cell induction (Manicassamy et al., 2009). In
addition, the β-catenin signaling pathway, although independent
of commensal triggering, appeared critical for the tolerogenic phe-
notype of lamina propria DCs by promoting IL-10 production
(Manicassamy et al., 2010). Okamura et al. (2009) identiﬁed lym-
phocyte activation gene-3 (LAG-3)-expressing Tr1-like cells in the
intestine, which developed on environmental microbiota. Induc-
tion of IL-10 production by Foxp3+ iTregs resulted in response
to polysaccharide A from the human commensal Bacteroides frag-
ilis and was largely dependent on TLR-2-signaling (Round and
Mazmanian, 2010). Thus, the generation of IL-10+ Tr1-like cells
but also Foxp3+ iTregs in the gut under steady state conditions is
heavily inﬂuenced by the localmicrobiological stimulation leading
to DC maturation and induction of costimulation via β-catenin,
TLRs, or presumably other signals.
INTRAVENOUS ANTIGEN, CONVERSION FROM ANERGIC T CELLS
In case of intravenous peptide-induced tolerance anergic T cells or
Tregs develop from naive precursors upon TCR receptor signaling
mostly in the absence of or with weak costimulation under these
steady state conditions (ThorstensonandKhoruts,2001; Jeon et al.,
2004; Safford et al., 2005). Intravenous antigen applications induce
Foxp3+ Tregs as well as Foxp3− Tr1 or Tr1-like cells both of which
require high afﬁnity TCR agonists (Gabrysova and Wraith, 2010;
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Gottschalk et al., 2010). While single injections of low doses of
peptides sufﬁce to generate Foxp3+ Tregs (Gottschalk et al., 2010),
their Tr1 or Tr1-like counterparts are formed after several repet-
itive injections of high doses of peptide (Gabrysova and Wraith,
2010). Whether antigen doses and application regimens are deci-
sive in this process is unclear. Most likely local environmental
differences such as the availability of TGF-β and all-trans retinoic
acid might further contribute to Foxp3 induction (Maynard et al.,
2007, 2009). In any case, these protocols follow antigen applica-
tions in the absence of inﬂammatory or microbial stimulation,
indicating that B7 costimulation may not be involved. Whether
the resulting IL-10+ cells in these assays are Tr1 or Tr1-like cells or
another subtype is unclear. On one hand they may be considered
as Tr1 cells because they are derived from naive T cells under low
costimulation conditions and not from polarized immunogenic
Th cells. On the other hand several rounds of stimulation with
strong antigenic and costimulatory conditions are more similar
to Tr1-like cells. Clear genetic markers would be needed to dis-
criminate between Tr1 cells, Tr1-like cells, and these IL-10+ T cells
described here to clarify this point.
ROLE OF COSTIMULATION FOR THE EXTRATHYMIC DE NOVO
CONVERSION OF Foxp3+ iTregs
Other major subtypes of Tregs are characterized by their expres-
sion of Foxp3. While natural Foxp3+ nTregs are directly released
from the thymus independent of DCs (Kyewski and Klein, 2006;
Ohkura and Sakaguchi, 2010), conversion of Foxp3+ iTregs occurs
in peripheral lymphatic organs by interactions with DCs. The
basal requirements for the development of Foxp3+ iTregs in vitro
and in vivo are deﬁned by TCR signaling and the presence of
the cytokines IL-2 and TGF-β (Figure 1; Fantini et al., 2004;
Davidson et al., 2007; Curotto de Lafaille and Lafaille, 2009). In
addition, costimulatory and coinhibitory molecules on the sur-
face of DCs importantly regulate the differentiation and functions
of iTregs from naive T cells (Bour-Jordan et al., 2011). Although
more and more costimulatory and coinhibitory molecules of the
B7 and TNF-families have been identiﬁed on DCs, which also
affect peripheral T cell tolerance, the deﬁnite requirements for
CD80/CD86 costimulation for Foxp3+ Treg biology are still under
debate and therefore will be discussed here. Also PD-L1/PD-L2
heavily contribute to Treg induction and function, which is dis-
cussed in more detail elsewhere (Francisco et al., 2010) but will be
brieﬂy touched below.
CD80/CD86 MOLECULES FOR Foxp3+ iTreg CONVERSION
Initial evidence that these costimulatory molecules might play a
role in Treg development reveal from studies using mice deﬁcient
for CD80/CD86 or CD28 or treated with the respective blocking
antibodies. In both cases, mice exhibited markedly reduced num-
bers of Foxp3+ Tregs in the thymus and the periphery (Salomon
et al., 2000; Bour-Jordan et al., 2004, 2011; Tang et al., 2004).
However, these studies did not discriminate between effects of
CD80/CD86 molecules on nTreg or iTreg development. First indi-
cations for peripherally induced iTregs come from investigations
on the conversion of naïve CD4+ CD25− T cells into CD4+
CD25+ Tregs after adoptive transfer into CD80/CD86−/− mice
(Liang et al., 2005). Under these conditions, naive CD4+ CD25−
T cells are unable to convert into Tregs, suggesting a role of
CD80/CD86 molecules in iTreg induction (Liang et al., 2005).
Although in this study Tregs were not deﬁned by expression of
Foxp3, these ﬁndings are in line with our in vivo conversion data
using a transgenic skin-antigen model and adoptive transfer of
antigen-speciﬁc naive CD25+ Foxp3− T cells (Azukizawa et al.,
2011). In this model, elevated levels of costimulatory molecules
were found on DCs migrating and transporting self-antigen under
these steady state conditions, thus representing a semi-mature
phenotype. These steady state migratory DCs induced peripheral
conversion of naive T cells into Foxp3+ iTregs, dependent on TGF-
β/latency-associated peptide (LAP) on the DC surface (Azukizawa
et al., 2011). This has been also described for speciﬁc tolerogenic
DC subsets in the intestine (Coombes et al., 2007; Sun et al., 2007)
and spleen (Yamazaki et al., 2008). Furthermore, mature bone
marrow-derived DCs could promote iTreg differentiation in vitro,
but only in the presence of exogenous TGF-β (Yamazaki et al.,
2007). These reports suggest that DCs of all maturation stages are
able to induce Foxp3 expressing iTregs, but the T cells prefer no or
low CD28 signals. A strict requirement seems TGF-β, which can
be either produced by DCs or is recruited from the environmental
milieu.
CD28 VERSUS CTLA-4 FOR iTreg CONVERSION
Several studies indicate that the maturation of DCs and therefore a
high costimulation is counteracting iTreg generation (Kretschmer
et al., 2005; Yamazaki et al., 2007; Wang et al., 2008). Kretschmer
et al. (2005) found that DC maturation in vivo upon injection of
agonist anti-CD40 antibodies diminished their potential to pro-
mote iTreg conversion. In vitro Treg conversion assays with splenic
DCs from CD80−/−/CD86−/− mice indicated that both mole-
cules on DCs are not directly required for the differentiation of
Foxp3+ iTregs (Yamazaki et al., 2007; Wang et al., 2008) but they
might promote the production of IL-2 by effector T cells, which
in turn enhances iTreg generation and maintenance (Yamazaki
et al., 2007). On the other hand, two studies using agonistic anti-
CD28 antibodies andCD80−/−/CD86−/− mice demonstrated that
at least a low CD28 costimulation was required for naive T cells
to become iTregs, whereas strong CD28 interaction induces the
differentiation of Teff cells (Benson et al., 2007; Semple et al.,
2011). In this context it has to be taken into account that both
effector T cells and Tregs themselves upregulate CD80 and CD86
on their surface after activation and CTLA-4+ Tregs even sup-
press effector T cells by ligating their CD80/CD86 molecules
(Paust et al., 2004). In this scenario also T–T cell communication
through CD28/CTLA-4 and CD80/CD86 can occur in the absence
of APCs and may contribute to Treg conversion. Together, CD28
costimulation appears to counter-regulate TGF-β dependent iTreg
conversion and survival in vitro but also in vivo (Figure 1).
UnlikeCD28costimulation the interactionbetweenCD80/CD86
molecules on DCs and CTLA-4 on T cells initially does not seem
to play a role in the development of Tregs, since CTLA-4−/− mice
exhibit normal numbers of Foxp3+ T cells (Tang et al., 2004;
Kataoka et al., 2005; Wing et al., 2008). Two groups further ana-
lyzed the role of CTLA-4 in the differentiation of iTregs using
CTLA-4 blocking antibodies and naive CTLA-4−/− T cells in Treg
conversion assays in vitro (Zeng et al., 2006; Wang et al., 2008).
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Both groups found a reduced induction of Foxp3 expressing iTregs
despite the presence of costimulation provided by anti-CD28 anti-
bodies or splenic DCs (Zeng et al., 2006; Wang et al., 2008). These
results cannot be explained simply by a different expression of
the CTLA-4 ligands CD80/CD86 by DCs, since high costimula-
tory levels by anti-CD28 antibodies and low costimulatory levels
by immature splenic DCs were used (Zeng et al., 2006;Wang et al.,
2008). Therefore, further investigations are needed to clarify the
role of CTLA-4 in iTreg development.
In this context the question remains, whether semi-mature
steady state migratory DCs are tolerogenic because of or despite
their costimulatory capacity. In agreement with previous results,
Benson et al. (2007) could show in ex vivo studies that CD80/CD86
molecules expressed by splenic DC inhibit iTreg conversion, but
administration of IL-2 and TGF-β in the absence or presence of
retinoic acid can overcome the inhibition of iTreg differentiation,
indicting a dominant role for IL-2 and TGF-β despite CD80/CD86
cosignaling. IL-2 production by DCs can hardly be detected under
steady state conditions (Granucci et al., 2003). However, steady
state migratory DCs employ endogenous TGF-β or the TGF-β
binding partner LAP to induce Treg conversion (Azukizawa et al.,
2011) and since these DCs are skin-derived and in close contact
with TGF-β producing keratinocytes, the environmental milieu in
which such migratory DCs were embedded might also affect their
tolerogenic potential.
Together, these observations suggest that immature costimu-
latorylow DCs have the highest capacity to induce iTregs in vivo and
in vitro, but costimulatoryint semi-mature and costimulatoryhigh
mature DC are still able to induce iTregs. The semi-mature DC
phenotype might reﬂect an evolutionary compromise between
partial activation to upregulate CCR7 and MHC II to enable their
migration to the lymphnodes and improvepresentationof periph-
eral self-antigens with only moderate CD80/CD86 upregulation.
In fact studies on human migratory DC indicated that they might
maintain an immature phenotype with respect to HLA-DR and
CD80/CD86 expression while CCR7 was upregulated (Geissmann
et al., 2002; Verbovetski et al., 2002).
PD-L1 AND PD-L2
PD-L1 is constitutively expressed by most hematopoietic cells and
can be further upregulated upon activation. In contrast, PD-L2 is
inducible on DCs, macrophages, and B cells. PD-L1 and PD-L2
both are the ligands of PD-1, which is expressed on activated B
and T cells as well as resting Tregs (Francisco et al., 2010). The role
of PD-L1 and PD-L2 for iTreg generation has been ﬁrst studied by
Noelle and colleagues, which showed that blocking of PD-L1, but
not of PD-L2, negatively affects the induction of Foxp3+ iTregs
by immature splenic DCs in vitro (Wang et al., 2008). The same
group also established a tumor antigen model demonstrating that
DC-derived PD-L1 was required for tumor-induced iTreg con-
version (Wang et al., 2008). PD-L1−/− mice used in this study
show signiﬁcant changes in their expression of other costimula-
torymolecules such asCD80,CD86, andCD40 (Wang et al., 2008).
PD-L1 and TGF-β play a synergistic role in the differentiation of
iTregs, since both factors alone induce less iTregs in vitro than in
combination (Francisco et al., 2009). In addition, mice deﬁcient
for PD-L1, PD-L2, and Rag1 have a decreased capacity to induce
iTregs in comparison with WT Rag1−/− mice (Francisco et al.,
2009).
In sum, these data suggest a pivotal role for DC-derived PD-L1
on iTreg development. All studies described above were performed
under steady state conditions or with isolated immature DC indi-
cating that the constitutive level of PD-L1 expressed by DC is
sufﬁcient for iTreg generation.
OTHER COSTIMULATORY AND COINHIBITORY MOLECULES FOR iTregs
Despite the importance of CD80/CD86 and PD-L1/PD-L2, other
regulatory molecules signiﬁcantly inﬂuence iTreg conversion.
Since further detailed review will be beyond the scope of this arti-
cle only two examples will be mentioned. Consistent with ﬁndings
from blocking CD80 and CD86 in vitro, CD40 blockage on splenic
DCs increased iTreg generation (Wang et al., 2008), supporting the
inhibitory effect of costimulation on Treg differentiation. In vitro
conversion assays with splenic DCs treated with an agonistic GITR
antibody showed a diminished induction of Foxp3+ T cells, indi-
cating also a costimulatory role of GITR in Treg conversion (Wang
et al., 2008).
ROLE OF DC COSTIMULATION FOR Foxp3+ nTreg
MAINTENANCE
TheTCR-speciﬁcities of natural Treg and effector T cell repertoires
are overlapping between 10 and 40%, depending on the study
(Hsieh et al., 2004; Pacholczyk et al., 2006; Wong et al., 2007).
Among the Tregs some recognize self-antigens and may continu-
ously undergo activation in those lymph nodes where steady state
migratory DCs transport and present peripheral tissue antigens
to speciﬁc T cells (Fisson et al., 2003), whereas others are speciﬁc
for foreign antigens derived from pathogens (Belkaid and Rouse,
2005; Kretschmer et al., 2005).
CD80/CD86
Dendritic cells can inﬂuence the expansion and survival of Tregs
by different mechanism. The interaction of CD80/CD86 mole-
cules with CD28 on Tregs is a major requirement for the thymic
development and the peripheral homeostasis of Tregs (Salomon
et al., 2000; Tang et al., 2003). Previous data by Bar-On et al. (2011)
support this idea since CD80/CD86 provided by DC was crucial
for maintenance of the peripheral Treg pool. In this study bone
marrow chimeras lacking CD80/CD86 speciﬁcally on DCs were
used, which result in a signiﬁcantly reduced frequency and num-
ber of Tregs in the periphery, but not in the thymus (Bar-On et al.,
2011). Thus, the costimulatory molecules CD80 and CD86 on DC
are required to mediate Treg homeostasis. In agreement with the
above described observations costimulatoryhigh mature antigen-
bearing DCs induce effectively Treg expansion in vitro and in vivo
(Yamazaki et al., 2003; Fehervari and Sakaguchi, 2004b). The pro-
liferation of Tregs in those studies was dependent on CD80/CD86
expressed by DCs and small amounts of IL-2 (Yamazaki et al.,
2003, 2007;Yamazaki and Steinman, 2009),which was mainly pro-
duced by effector T cells and not DCs (Fehervari and Sakaguchi,
2004b). Of note, costimulatorylow immature DCs are less effective
than mature DCs in promoting Treg expansion in vitro (Fehervari
and Sakaguchi, 2004a). However, under steady state conditions
only immature and semi-mature DCs with basal to intermedi-
ate levels of costimulatory molecules are present in secondary
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lymphoid organs (Azukizawa et al., 2011). Fully mature DC phe-
notypes appear upon infection or inﬂammation (Lutz and Schuler,
2002) and therefore cannot play a role in Treg homeostasis. Rather
mature DCs are suggested to be required for the induction of pro-
tective effector T cell responses and its subsequent control by Treg
in twoways. First,matureDCs secrete pro-inﬂammatory cytokines
like IL-6, which inhibit the suppressive activity of Tregs (Fehervari
and Sakaguchi, 2004a). Second,by interacting of CD80/CD86with
CD28 on Tregs mature DCs may induce expansion of Tregs at the
peak of the immune response resulting in the suppression of effec-
tor T cells. It remains to be determined how semi-mature DCs in
comparison to immature DCs affect peripheral Treg numbers.
In this context it has to be considered that under steady state
conditions lymph node resident immature DCs and migratory
semi-mature DCs present self-antigens of different sources (Lutz
et al., 2010; Azukizawa et al., 2011). While migratory DC take
up low doses of soluble or cell-associated self-antigens in periph-
eral tissues, lymph node resident immature DC can only capture
and present high doses of soluble antigens transported from the
conduit system (Sixt et al., 2005).
IL-2
As mentioned above, DCs are also required for Treg homeostasis
by inducing IL-2 production in effector T cells (Yamazaki et al.,
2003, 2007; Fehervari and Sakaguchi, 2004a). IL-2, rather than IL-
7 and IL-15, is an essential growth factor for Tregs to survive and
expand in the periphery (Figure 1; Almeida et al., 2002; Malek
et al., 2002; D’Cruz and Klein, 2005; Setoguchi et al., 2005). To
induce IL-2 expression in effector T cells, B7/CD28 interaction
between DCs and effector T cells is required (Tang et al., 2003;
Yamazaki et al., 2003, 2007). However, the contribution of DC-
derived IL-2 in Treg homeostasis is controversial. Whereas several
in vitro studies have revealed that IL-2 secretedbyDCsplays no role
in Treg maintenance (Yamazaki et al., 2003, 2007; Fehervari and
Sakaguchi, 2004a), another study indicated that DC-Treg inter-
action via CD40/CD40L induces IL-2, which is required for Treg
expansion (Guiducci et al., 2005). However, DCs have been shown
to produce IL-2 only upon microbial activation but not under
steady state conditions (Granucci et al., 2003). Thus, the question
remains whether immature and semi-mature DCs under steady
state conditions are capable to produce IL-2 and if so, what is its
relevance for Tregs.
Fms-LIKE TYROSINE KINASE 3 LIGAND
The control of Treg homeostasis has also been linked to DC num-
bers and the level of Fms-like tyrosine kinase 3 ligand (Flt3L; Liu
et al.,2003;Darrasse-Jeze et al.,2009; Swee et al.,2009; Suffner et al.,
2010). Flt3L is a hematopoietic growth factor supporting prolifer-
ation and differentiation of DC precursors (Karsunky et al., 2003;
Liu et al., 2003). Repetitive injections of Flt3L into mice resulted
not only in an increased number of DCs, but also enhanced the
proliferation of peripheral nTregs (Swee et al., 2009). In vitro
experiments by the same group indicated that Flt3L-mediated
nTreg expansion was directly dependent on DC contact and IL-2,
but not on TCR engagement (Swee et al., 2009). In contrast, earlier
studies showed that fully mature DC generated from bone marrow
by GM-CSF most efﬁciently induced Treg expansion (Yamazaki
et al., 2003), while both immature and mature Flt3L-generated
bone marrow-derived DCs had a similar capacity to promote Treg
proliferation (Swee et al., 2009). Others claimed that a feedback
loop exists,which regulates the homeostasis of both Tregs andDCs
in a Flt3L- and MHC II-dependent manner (Darrasse-Jeze et al.,
2009; Hochweller et al., 2009).
TONIC SIGNALS FROM MHC II MOLECULES
Under steady state conditions T cells scan self-MHC molecules to
achieve basal activation state enabling a faster subsequent response
upon recognition of foreign antigens (Stefanova et al., 1989). A
recent study by Hochweller et al. (2010) revealed that the respon-
siveness of T cells toward their cognate antigen speciﬁcally depends
on the recognition of self-MHC molecules on DCs but not other
APC. Since Tregs express a TCRwith a higher afﬁnity for self-MHC
molecules as compared to effector T cells, it was found by two-
photon microscopy in situ that antigen-presenting DCs interact
for longer periods with TCR transgenic antigen-speciﬁc Tregs than
effector T cells (Tadokoro et al., 2006; Tang et al., 2006). It would
be interesting to investigate if such tonic TCR signals also play a
role in Treg homeostasis in vivo. An initial study showed that inac-
tivation of Lck in Tregs and thereby abrogating their TCR signaling
results in an impaired proliferation and homeostatic expansion of
those Tregs (Kim et al., 2009). These data indicate that DC–T cell
interaction via TCR and MHC II molecules affect the maintenance
of Tregs.
In sum, these observations strongly support a crucial role of
DCs in Treg homeostasis and demonstrate that DCs affect the pro-
liferation of Tregs by several mechanisms such as their expression
of costimulatory molecules, surface TGF-β/LAP, the induction of
IL-2 production and their frequency in lymphoid organs.
SUPPRESSIVE ACTIVITY OF Tregs ON DCs
Despite the fact that numerous effector mechanism for Treg-
mediated suppression have been described (Roncarolo et al., 2006;
Sakaguchi et al., 2008; Shevach, 2009; Yamazaki and Steinman,
2009; Weiner et al., 2011), the question remains, whether Tregs
can act directly on effector T cells or all regulation occurs indi-
rectly through DCs or other APCs? Clearly, Tregs can directly
suppress T cell responses in vitro since APC-free co-cultures of
Tregs and effector T cells, stimulated by CD3 and CD28 anti-
bodies, show suppressive activities (Dieckmann et al., 2002). On
the other hand major suppression mechanisms can also act on
DCs, as described below. The relative contribution of both Treg
targeting strategies in vivo is less well understood (Miyara and
Sakaguchi, 2007; Shevach, 2009). Our own ﬁndings indicated that
both direct and indirect mechanisms occur simultaneously in the
spleen by using adoptively transferred DCs and CD4+ CD25+
Foxp3+ Tregs. In this setting the indirect effect on DC exceeded
the direct suppression of effector T cells (Hänig and Lutz, 2008).
COMPETITION FOR DC
Some published data suggest that Tregs interfere with the ability
of DCs to activate effector T cells, either by physically obstruct-
ing effector T cells to DCs contact as shown in vitro (Onishi
et al., 2008). However, competition could not be conﬁrmed in vivo
during effector T cell responses or under regulatory conditions
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even using high numbers of adoptively transferred mature DCs,
Tregs and effector T cells and then following the cluster formation
and sizes in spleens of mice (Hommel and Kyewski, 2003; Hänig
and Lutz, 2008). Most probably, the three dimensional and highly
dynamic T cell turnover in lymphatic organs cannot be reﬂected
in vitro where DCs highly aggregate homotypically via E-cadherin
interaction (Jakob and Udey, 1998; Riedl et al., 2000; Jiang et al.,
2007).
TREGS PREVENT DC MATURATION
Tregs preclude upregulation of costimulatory molecules such as
CD80, CD86, PD-L1, PD-L2, and CD40 but also the number of
MHC-peptide complexes. In addition Tregs may reduce the pro-
duction of inﬂammatory cytokines by DCs such as IL-12, IL-1β,
IL-6, and IL-8 (Fallarino et al., 2003; Misra et al., 2004; Feunou
et al., 2007; Larmonier et al., 2007; Hänig and Lutz, 2008; Wing
et al., 2008; Andre et al., 2009). Many of these functions remained
unexplained or could be attributed to soluble factors like IL-10 or
TGF-β production by Tregs as discussed above for IL-10 by Tr1
and Tr1-like cells.
Treg SURFACE MARKERS: LAG-3, CD39
Onishi et al. (2008) showed that DC-Treg aggregation occurs as
a ﬁrst step where LAG-3, a CD4-related transmembrane protein,
expressed by Tregs and activated effector T cells binds MHC II
molecules on DCs, followed by CTLA-4-dependent prevention
of CD86 upregulation. Additional function of LAG-3 has been
described, proving that LAG-3 expressed on the Tregs surface
leads to MHC II molecule crosslinking and consequential Erk-
mediated recruitment of SHP-1 responsible for the inhibition of
DC maturation l (Liang et al., 2008).
Another surface molecule with immunosuppressive activ-
ity expressed by Tregs is CD39 (nucleoside triphosphate
diphosphohydrolase-1), an ectoenzyme that degrades ATP to
AMP. Extracellular ATP has an adjuvant feature in inﬂammation
(Gallucci et al., 1999), whereas its degradation product AMP acts
anti-inﬂammatory (Kumar and Sharma, 2009). CD39 expression
is constitutive in Tregs and controlled by Treg master transcription
factor Foxp3. After TCR ligation, the activity of membrane-bound
CD39 increases (Borsellino et al., 2007).
Treg SOLUBLE MEDIATORS: IL-10, TGF-β, IDO, GLUTHATHIONE
In the early nineties it has been demonstrated that exogenous
or Th cell-produced IL-10 can inhibit costimulatory function of
macrophages, Langerhans cells, andDCs (Ding and Shevach, 1992;
Caux et al., 1994; Péguet-Navarro et al., 1994). In most of the stud-
ies exogenous IL-10 was used, although Ding and Shevach (1992)
designated a Th2 subset as a source of this cytokine. Activated Tr1
or Tr1-like cells are the source of IL-10 and as such prevent DC
maturation (see above). Similar effects were observed with TGF-β
(Epstein et al., 1991; Bonham et al., 1996). Soon after Tregs were
discovered, it was found that this cell population represents the
source for both cytokines and can inhibit DC maturation in a sim-
ilar manner as exogenous cytokines (Hara et al., 2001; Suri-Payer
and Cantor, 2001; Belghith et al., 2003; Li et al., 2007).
Tregs express high level of CTLA-4 and several CTLA-4-
dependent mechanisms exist through which Tregs inhibit DC
function. DCs incubated with CTLA-4+ Tregs or CTLA-4–Ig
fusion proteins triggering CD80/CD86 lead to indoleamine 2,3-
dioxygenase (IDO) production (Fallarino et al., 2003; Feunou
et al., 2007). The major effect of IDO is tryptophan degrada-
tion, causing its depletion, and the production of proapoptotic
metabolites.
Another effect of the CTLA-4 interaction is Treg-mediated
redox perturbation. In this case, Treg-DC contact results in CTLA-
4-dependent diminished glutathione (GSH) synthesis in DCs
via decreased expression of γ-glutamylcysteine synthetase, the
limiting enzyme for GSH synthesis (Yan et al., 2010).
Altogether, Treg-modiﬁed DCs maintaining an immature or
only semi-mature status are incapable of eliciting strong, produc-
tive immune responses, and lead to induction of tolerance.
DOWNREGULATION OF COSTIMULATORY MOLECULES FROM THE
MATURE DC SURFACE
While prevention of DC maturation could be a signiﬁcant reg-
ulatory mechanism to avoid unwanted immunity, the question
remains to which extent are mature/activated DCs sensitive to
Treg cell inhibitory action? This topic has been partially assessed
by several groups. Some authors claim that strong TLR-stimuli
completely abrogate auto-regulation (Pasare andMedzhitov, 2003;
Iwasaki and Medzhitov, 2004; Kabelitz et al., 2006). Further-
more, inﬂammatory cytokines produced by activated DCs seem
to impede Treg functions (King and Segal, 2005; Valencia et al.,
2006; Wan et al., 2007). On the other hand, although not directly
addressing this question in the light of time kinetics,Veldhoen et al.
(2006) could show that the repertoire of cytokine production of
the LPS- and CpG-matured DCs changes from inﬂammatory to
immunosuppressive depending on the presence of Tregs in the
cultures. This result partially opposes the previous claim that
strong TLR-stimuli completely disqualify Treg effects. Our own
group and that of Santamaria could show that mature DCs are
only partially sensitive to Tregs by modulating CD80/CD86 and
PD-L1/PD-L2 but no other markers, since the Treg effect could
be abrogated by CD40 licensing (Serra et al., 2003; Hänig and
Lutz, 2008). Although not using additional stimuli for DC matu-
ration beside KLH and OVA, a study of Oldenhove et al. (2003)
presented convincing set of data pointing to the ability of Tregs
to attenuate Th1 responses initiated by transfer of mature DCs.
Remarkably, Treg depletion in the same model reﬂected negatively
onTh2development. Recently, amechanism for the disappearance
of CD80 andCD86molecules onApPCswas provided by amecha-
nism called trans-endocytosis, meaning the removal of individual
CD80/CD86 molecules but not whole membrane patches (trogo-
cytosis) out of theAPC membrane by CTLA-4 molecules (Qureshi
et al., 2011). The captured molecules are then rapidly inter-
nalized, explaining the known high turnover and predominant
intracellular expression of CTLA-4.
CONCLUSION
All available data indicate that DCs interact by many means with
T cells not only for induction of effector T cells but also to gen-
erate and maintain Tregs and in turn also to be controlled by
Tregs. While TCR-speciﬁc activation is required for all Treg sup-
pressor functions so far, the induction of Tr1 or Tr1-like cells
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clearly requires alsoCD80/CD86 costimulation. Tr1 orTr1-like cell
generationmay be further supported by IL-10. In contrast, Foxp3+
iTreg generation occurs more efﬁcient without CD80/CD86 sig-
nals and requires TGF-β. The maintenance and activation of
nTreg is strongly supported by high levels of CD80/CD86 and
IL-2. Finally a major control mechanism of mature, but not
CD40-licensed, DCs occurs through CTLA-4-dependent activity
on CD80/CD86 molecules by trans-endocytosis and IDO induc-
tion at theDC-Treg interface. Future research activities,whichhave
to consider also the CD80/CD86 expression on activated Tregs and
effector T cells,will lead to amore complete understanding of these
molecules and how this can be exploited to develop new therapies.
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